Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial

Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:33:28.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:00:59.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the previous study record content with a basic site layout indicating access is blocked.
    Difference
    15%
    Check dated 2026-09-20T00:57:47.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.6.6 has been added to the study record, replacing the previous v3.6.5 to indicate an applied update. The change represents a metadata refresh and does not modify the study details, eligibility criteria, or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-08-29T20:56:12.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a minor version update to the page rather than any alteration to study data.
    Difference
    0.1%
    Check dated 2026-08-08T20:59:42.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, signaling a minor platform update. No study content or results appear to be affected.
    Difference
    0.1%
    Check dated 2026-07-25T13:00:34.000Z thumbnail image

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.